AAPG
Ascentage Pharma Group International
15.90$
-2.5%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -598.6% | -1,706.5% | -3,491.5% | -3,171.7% | -4,899.2% | -2,166.5% | -311.8% | -327.1% | -11.4% | -210.2% | |
| 2.1% | 197.6% | 271.2% | 26.4% | 220.3% | 101.5% | 30.0% | 42.0% | 9.5% | 15.5% | |
| 847.7% | – | 405.1% | 488.0% | 594.6% | 168.3% | 10.5% | 14.2% | 2.1% | 3.7% | |
| 28.0% | 166.4% | 397.8% | 76.8% | -443.8% | -268.4% | 49.8% | -4.1% | 11.3% | -25.7% | |
| 44.0% | 324.5% | 726.6% | 561.0% | 2,019.9% | 1,564.4% | 113.0% | 25.6% | 2.5% | 4.9% | |
| -2,082.1% | -3,640.1% | 4,301.6% | -1,387.3% | -862.4% | -1,671.5% | -183.4% | 9.9% | -36.9% | -179.1% | |
| – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | 0.0% | -92.7% | -12.8% | -2.7% | 0.0% | -1.6% | |
| – | – | – | – | – | 1,933.0% | 331.8% | -6.0% | -14.8% | 55.0% | |
| 5,950.0% | 922.3% | 12,636.4% | 3,048.0% | 8,353.4% | 6,382.6% | 295.3% | 166.1% | 32.1% | 454.8% | |
| 3,841.5% | -4,420.2% | 13,842.6% | -1,502.8% | 2,257.0% | 2,461.2% | -172.3% | -138.6% | -14.8% | 54.2% | |
| -642.5% | -2,031.0% | -4,218.1% | -3,732.7% | -6,919.1% | -3,730.9% | -424.8% | -352.7% | -13.8% | -215.2% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.